Valproic Acid
Product Images NDC 17856-0675

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 17856-0675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (17856 0675 01)

Image 1 (17856 0675 01)
This is a description of Valproic Acid Oral Solution, USP 250 mg/5mL. The medication comes in a package and the dosage should be determined based on the package insert. It should be stored at 20° to 25°C. There is a caution to keep the medication out of the reach of children. The medication is distributed by Atlantic Biologicals Corp and the phone number for reordering is 800.509.7592.*
FDA Label Image

Chemical Structure (Valproic 01)

FDA Label Image

Figure 1 (Valproic 02)

Figure 1 (Valproic 02)
The text appears to be a table depicting the percentage reduction in CPS (Central Nervous System) rate for a medicine called Divalproex Sodium versus a Placebo. The table displays three columns and three rows with the first column representing the percentage reduction rate of CPS and the second column represents the percentage of patients showing an improvement or worsening of their condition. The third column is not available.*
FDA Label Image

Figure 2 (Valproic 03)

Figure 2 (Valproic 03)
This appears to be a table showing the reduction in the CPS (Central Processing System) rate and the percentage of patients that experienced improvement, no change, or worsening.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.